1998•Europe PMC (PubMed Central)Requires access

Preparation of recombinant retrovirus vectors containing human interleukin-2 gene and its transfection into leukemia cells

Fang Yin, Baisong Wu, Qifa Liu, Weiyang Zheng, Bin Wu, Shu-Yun Zhou

Open publisher page 0 citations

Abstract

Recombinant retrovirus vectors containing human IL-2 gene were packaged with PA317 packaging cells. The supernatants containing recombinant retroviruses were used to infect leukemia cell lines K562 and HL-60. The presence of neomycin-resistant (neoR) gene was confirmed by Southern blot and the IL-2 activities were measured by MTT method. Thus human IL-2 gene was successfully transfected into K562 and HL-60 cells. The results showed that the leukemia cells transfected with human IL-2 gene grew much more slowly than those untransfected or transfected with control vectors. The agar colonogeneicity assay also showed that the colony number of IL-2 gene-transfected cells was much less than that of untransfected cells or cells transfeced with control vectors. Therefore, the proliferation activity of leukemia cells transfected with IL-2 gene was reduced.

About this research paper

What this paper is about

Recombinant retrovirus vectors containing human IL-2 gene were packaged with PA317 packaging cells. The supernatants containing recombinant retroviruses were used to infect leukemia cell lines K562 and HL-60. The presence of neomycin-resistant (neoR) gene was confirmed by Southern blot and the IL-2 activities were measured by MTT method. Thus human IL-2 gene was successfully transfected into K562 and HL-60 cells. The results showed that the leukemia cells transfected with human IL-2 gene grew much more slowly than those untransfected or transfected with control vectors. The agar colonogeneicity assay also showed that the colony number of IL-2 gene-transfected cells was much less than that of untransfected cells or cells transfeced with control vectors. Therefore, the proliferation activity of leukemia cells transfected with IL-2 gene was reduced.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Recombinant retrovirus vectors containing human IL-2 gene were packaged with PA317 packaging cells. The supernatants containing recombinant retroviruses were used to infect leukemia cell lines K562 and HL-60. The presence of neomycin-resistant (neoR) gene was confirmed by Southern blot and the IL-2 activities were measured by MTT method. Thus human IL-2 gene was successfully transfected into K562 and HL-60 cells. The results showed that the leukemia cells transfected with human IL-2 gene grew much more slowly than those untransfected or transfected with control vectors. The agar colonogeneicity assay also showed that the colony number of IL-2 gene-transfected cells was much less than that of untransfected cells or cells transfeced with control vectors. Therefore, the proliferation activity of leukemia cells transfected with IL-2 gene was reduced.

Key concepts: Transfection, K562 cells, Retrovirus, Recombinant DNA, Molecular biology, Leukemia, Biology, Cell culture

Related papers

Back to paper searchBrowse research topicsOriginal source
Preparation of recombinant retrovirus vectors containing human interleukin-2 gene and its transfection into leukemia cells — Research Paper | ScholarLens